Device typeCancer antigen 125 (CA125) IVD, kit, enzyme immunoassay (EIA): A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer, in a clinical specimen using an enzyme immunoassay (EIA) method.
FDA categoryTEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)
Device ID00816870020471
Catalog number3025-300A
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information
Width7.75 Inch